Disseminated Amphotericin-Resistant Fusariosis in Acute Leukemia Patients: Report of Two Cases
MetadataShow full item record
Disseminated fusariosis has emerged as a significant, usually fatal infection in immunocompromised hosts despite antifungal treatment. We describe here two patients with acute leukemia who developed disseminated amphotericin-resistant fusariosis, and review of six studies of cases series in the literature. Two Fusarium solani strains were isolated from blood and skin cultures of one patient, and one strain from the blood culture of the second patient. Both patients died despite antifungal treatment. Strains were identified by sequencing of ITS1 and ITS4 regions. Random amplified polymorphic DNA analysis of the three F. solani isolates showed a low degree of similarity. Screening for Fusarium spp. contaminants within our facility was negative. Using the CLSI M-38-A2 broth dilution method and E tests®, we found that the MICs were low for voriconazole (0. 12 and 0. 5 mg/L, respectively), unexpectedly high for amphotericin B (≥8 and ≥32 μg/mL, respectively) and itraconazole (≥16 mg/ml). Patients with leukemia or persistent neutropenia should be assessed for disseminated fungal infections, including biopsy and skin cultures. Antifungal susceptibility tests are important due to the possibility of the strains being amphotericin resistant. Treatments must be aggressive, with high doses of antifungals or combined therapy. © 2012 Springer Science+Business Media Dordrecht.
How to cite this document
Showing items related by title, author, creator and subject.
Characterization of myeloid or lymphoid acute leukemia by a chemiluminescence assay: Comparison with immunocytochemistry using an antimyeloperoxidase antibody Fonseca, Luiz Marcos da ; Brunetti, Iguatemy Lourenço ; Rego, E. M. ; Garcia, A. B. ; Cilento, G. ; Falcao, R. P. (Acta Haematologica, 1993) [Artigo]A simple and sensitive chemiluminescence assay for the demonstration of the activity of intracellular myeloperoxidase (MPO) is described, which is useful for the distinction between myeloid and lymphoid commitment in blasts ...
Clinical outcome in chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation: The experience of the Bone Marrow Transplantation Unit of FUNFARME/BRAZIL using FISH Vendrame-Goloni, C. B. ; Carvalho-Salles, A. B.; Ruiz, M. A.; Ricci, O.; Varella-Garcia, M.; Fett-Conte, A. C. (Genetics and Molecular Research, 2008) [Artigo]Investigation of the efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in chronic myeloid leukemia patients is essential to predict prognosis and survival. In 20 patients treated at the Bone Marrow ...
Fernandes Gomes, Mônica ; Rodrigues Kohlemann, Katya; Plens, Glauco; Silva, Marcelo Milone; Pontes, Elitânia Marinho; Da Rocha, João Carlos (Quintessence International, 2005) [Artigo]A 14-year-old, male patient was referred for the treatment of mucositis, idiopathic facial asymmetry, and candidiasis. The patient had been undergoing chemotherapy for 5 years for acute lymphoblastic leukemia. He presented ...